Cell therapy appears safe and effective for l
<p>A study led by researchers at <a href="https://umiamihealth.org/en/sylvester-comprehensive-cancer-center"><strong>Sylvester Comprehensive Cancer Center</strong></a> suggests that CAR-T immunotherapy remains a viable option for patients who have lymphoma that goes into remission before the cell therapy begins. Video available.</p>
Source: eurekalert.org